In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Xoma Corp (NASDAQ:XOMA) reported that Biotechnology Value Fund L P has picked up 695,726 of common stock as of 2017-02-21.
The acquisition brings the aggregate amount owned by Biotechnology Value Fund L P to a total of 695,726 representing a 9.2% stake in the company.
For those not familiar with the company, XOMA Corporation (NASDAQ:XOMA) is a biotechnology company with a diverse portfolio of innovative therapeutic antibodies. The Company’s innovative product candidates are the result of its expertise in developing ground-breaking monoclonal antibodies, which have created new opportunities to potentially treat a wide range of endocrine diseases.
A glance at Xoma Corp (NASDAQ:XOMA)’s key stats reveals a current market capitalization of 39.56 million based on 7.52 million shares outstanding and a price at last close of $5.16 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2013-08-19, Baker picked up 21,410 at a purchase price of $3.62. This brings their total holding to 510,449 as of the date of the filing.
On the sell side, the most recent transaction saw Neal unload 95 shares at a sale price of $4.50. This brings their total holding to 20,471.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Xoma Corp (NASDAQ:XOMA) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
